Bio View stock analysis
Bio View (BIOV) Stock Price & Analysis
BIOV Stock Chart & Stats
- Day’s Range
- ILA 4,510.00 - ILA 4,949.00
- 52-Week Range
- ILA 4,050.00 - ILA 29,400.00
- Previous Close
- ILA 4,507.00
- Volume
- N/A
- Average Volume (3M)
- 399
- Market Cap
- ILS 7.00M
- Enterprise Value
- ILS 11.95T
- Total Cash (Recent Filing)
- ILS 8.17M
- Total Debt (Recent Filing)
- ILS 2.10M
- Price to Earnings (P/E)
- ―
- Beta
- 0.18
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Mar 22, 2017
- Dividend Yield
- N/A
BIOV FAQ
What was Bio View’s price range in the past 12 months?
What is Bio View’s market cap?
When is Bio View’s upcoming earnings report date?
How were Bio View’s earnings last quarter?
Is Bio View overvalued?
Does Bio View pay dividends?
What is Bio View’s EPS estimate?
How many shares outstanding does Bio View have?
What happened to Bio View’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Bio View?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Bio View
Bio-View Ltd, founded in 2000 and headquartered in Rehovot, Israel, is a developer, manufacturer, and global distributor of advanced automated cell imaging and analysis systems. These sophisticated solutions are utilized by clinical and research laboratories worldwide, specifically in the fields of cytology, cytogenetics, and pathology. The company's extensive product lineup includes: Accord: A semi-automated fluorescent imaging and analysis workbench microscope station. Accord Plus: An automatic fluorescent imaging system capable of real-time scanning, analysis, and sorting of diverse FISH (Fluorescence In Situ Hybridization) samples. Allegro Plus: Another automatic fluorescent imaging system engineered to pinpoint various chromosomal aberrations under fluorescent light, such as amplifications, translocations, inversions, and deletions. DUET-3: An imaging and analysis platform featuring an automated barcode reader, which streamlines the processing of multiple test types within a single scan batch. DeNovo: An automated scanning system dedicated to the precise detection, analysis, and characterization of circulating tumor cells found in peripheral blood. Solo Workstation & Solo Touch Workstation: These are offline and standalone workstations, respectively, providing advanced tools for reviewing and analyzing test results remotely from the microscope. SoloWeb: A comprehensive web-based solution that enables remote analysis, reporting, and expert consultation on cases scanned using Bio-View's systems. Furthermore, Bio-View Ltd has established a strategic partnership with ANGLE plc to jointly develop a liquid biopsy circulating tumor cell HER2 assay, specifically targeting breast cancer.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Daniel Klain
- Employees
- 30
- Website
- www.bioview.com
- Address
- 3 Pekeris Street, Rehovot, HM, 7670203, IL
Bio View (BIOV) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |

